AAAAAA
Results:
1-7
|
Results: 7
Authors:
Schmidt, H
Geertsen, PF
Fode, K
Rytter, C
Bastholt, L
von der Maase, H
Citation: H. Schmidt et al., Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study, MELANOMA RE, 10(1), 2000, pp. 66-77
Authors:
Baekke, J
Rytter, C
Mouridsen, H
Madsen, EL
Moholt, K
Bastholt, L
Citation: J. Baekke et al., A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma, ACTA ONCOL, 39(5), 2000, pp. 625-628
Authors:
Eriksen, JG
Bastholt, L
Krogdahl, AS
Hansen, O
Joergensen, KE
Citation: Jg. Eriksen et al., Esthesioneuroblastoma - What is the optimal treatment?, ACTA ONCOL, 39(2), 2000, pp. 231-235
Authors:
Thorn, JJ
Hansen, HS
Specht, L
Bastholt, L
Citation: Jj. Thorn et al., Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation, J ORAL MAX, 58(10), 2000, pp. 1088-1093
Authors:
Rose, C
Kamby, C
Mouridsen, HT
Andersson, M
Bastholt, L
Moller, KA
Andersen, J
Munkholm, P
Dombernowsky, P
Christensen, IJ
Citation: C. Rose et al., Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer - A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone and tamoxifen plus fluoxymesterone in women above 65 years of age, BREAST CANC, 61(2), 2000, pp. 103-110
Authors:
Sorensen, P
Andersen, LJ
Hansen, O
Bastholt, L
Citation: P. Sorensen et al., Long-term continuous 5-fluorouracil infusion in patients with advanced head and neck cancer, ACTA ONCOL, 38(8), 1999, pp. 1043-1045
Authors:
Bonnema, SJ
Bertelsen, H
Mortensen, J
Andersen, PB
Knudsen, DU
Bastholt, L
Hegedus, L
Citation: Sj. Bonnema et al., The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: Effect on thyroid function and size and pulmonary function, J CLIN END, 84(10), 1999, pp. 3636-3641
Risultati:
1-7
|